Abiopharma

Clinical trial NCT03409432: collaborators added: Celgene Corporation.

Clinical trial NCT07265258 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2025-12-30 → 2026-07-30 3. completion date: 2027-09-04 → 2028-12-30 4. primary completion date: 2026-09-12 → 2028-06-30

Odysight.ai Reports Financial Results for the First Half of 2026 and Provides Business Update

Kimberly-Clark Appoints Suzana Blades as Senior Vice President and General Counsel

Odysight.ai signs agreement with Boeing to demonstrate AI-Powered capabilities

SuperCom Reports Record Revenue and Record EBITDA of $4 Million in the Second Quarter of 2026

Ideal Power Reports Second Quarter 2026 Financial Results

ARX Stock Alert: Halper Sadeh LLC is Investigating Whether Accelerant Holdings is Obtaining a Fair Price for its Shareholders

Virtuix to Highlight Accelerating Consumer Growth and Expansion Across Defense, Robotics, and Healthcare at Sidoti Investor Conference

OPKO Health Expands Strategic Relationship with HealthCare Royalty Through $125 Million Notes Issuance Secured by Mazdutide Royalty Interests